CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q2 2023

Type / Class
Equity / COM
Symbol
CRBP on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$83 0
2023 Q1 100 $595 -$1,309,775 $5.95 1
2022 Q4 11,873,639 $1,310,869 -$1,836,736 $0.11 58
2022 Q3 23,309,954 $3,846,472 -$1,485,869 $0.16 50
2022 Q2 31,805,171 $8,026,934 -$1,890,586 $0.25 56
2022 Q1 37,459,566 $19,684,954 -$3,817,950 $0.53 59
2021 Q4 44,531,209 $27,243,487 -$708,085 $0.62 69
2021 Q3 44,693,232 $45,446,409 -$6,301,434 $1.02 74
2021 Q2 49,613,842 $90,932,370 +$10,573,210 $1.83 91
2021 Q1 43,743,575 $86,162,345 +$10,398,659 $1.97 102
2020 Q4 39,109,566 $48,895,291 -$23,698,920 $1.25 97
2020 Q3 56,213,687 $101,187,932 -$33,267,977 $1.80 111
2020 Q2 45,655,185 $383,000,051 +$88,575,586 $8.39 134
2020 Q1 35,187,567 $184,378,846 +$22,611,914 $5.24 102
2019 Q4 30,832,276 $168,344,201 -$6,930,688 $5.46 96
2019 Q3 31,812,945 $154,933,393 -$4,587,380 $4.87 96
2019 Q2 32,374,425 $224,347,596 +$62,327,166 $6.93 91
2019 Q1 23,632,595 $164,248,305 -$11,828,389 $6.95 94
2018 Q4 25,930,294 $151,655,020 +$22,698,365 $5.84 76
2018 Q3 21,964,785 $165,632,209 -$3,060,083 $7.55 75
2018 Q2 22,567,367 $114,259,639 +$7,134,149 $5.05 77
2018 Q1 23,559,925 $144,228,866 +$12,279,533 $6.10 75
2017 Q4 21,145,425 $150,348,128 +$41,492,540 $7.10 85
2017 Q3 15,275,104 $109,216,902 -$4,540,752 $7.15 67
2017 Q2 15,957,390 $100,528,245 +$6,772,411 $6.30 65
2017 Q1 14,006,967 $115,546,313 +$14,480,659 $8.25 53
2016 Q4 13,013,996 $109,971,000 +$12,131,222 $8.45 49
2016 Q3 11,797,557 $79,413,000 +$12,222,233 $6.79 40
2016 Q2 10,235,318 $30,600,000 +$15,254,008 $2.99 24
2016 Q1 5,172,213 $9,367,000 +$329,459 $1.81 21
2015 Q4 5,004,201 $8,251,000 +$62,688 $1.65 21
2015 Q3 4,969,812 $7,809,000 +$2,938,748 $1.57 19
2015 Q2 3,097,688 $9,541,000 +$9,541,000 $3.08 13